Alembic Ltd

alembiclimited.com BSE: 506235 NSE : ALEMBICLTD
About [ edit ]

Alembic is dealing in Active Pharmaceutical Ingredient (API) Business and Real Estate Business.

Website BSE NSE
  • Market Cap ₹ 3,450 Cr.
  • Current Price ₹ 134
  • High / Low ₹ 143 / 46.0
  • Stock P/E 8.93
  • Book Value ₹ 74.3
  • Dividend Yield 0.45 %
  • ROCE 7.00 %
  • ROE 25.0 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 25.19% CAGR over last 5 years

Cons

  • The company has delivered a poor sales growth of -12.48% over past five years.
  • Tax rate seems low
  • Earnings include an other income of Rs.65.79 Cr.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
33 45 34 24 25 26 24 13 11 13 17 14
33 36 27 21 22 25 21 13 12 13 14 11
Operating Profit 0 8 6 3 3 1 3 -0 -1 1 2 4
OPM % 0% 19% 19% 13% 13% 5% 11% -1% -6% 6% 15% 27%
Other Income 3 1 24 2 2 1 33 2 57 3 3 3
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 1 1 1 1 1 1 1 1 1 1 1 1
Profit before tax 3 9 30 4 5 2 34 1 56 3 4 6
Tax % -81% 22% 2% 17% 19% 30% -2% 2% 0% 17% 22% 16%
Net Profit 33 34 88 53 56 37 109 68 115 89 97 86
EPS in Rs 1.24 1.31 3.44 2.06 2.16 1.43 4.24 2.65 4.49 3.45 3.77 3.33
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 TTM
990 1,099 1,121 144 134 147 125 124 74 56
848 1,016 1,018 134 131 143 114 106 71 50
Operating Profit 142 83 103 10 3 5 11 18 3 6
OPM % 14% 8% 9% 7% 3% 3% 9% 15% 4% 12%
Other Income 39 7 16 21 28 27 37 29 93 66
Interest 35 42 32 1 0 0 0 0 0 0
Depreciation 33 38 43 6 6 5 4 3 3 4
Profit before tax 114 9 44 23 25 27 44 45 93 68
Tax % 1% -19% 10% -3% 2% -3% 5% 8% 0%
Net Profit 112 11 40 107 235 145 163 213 329 386
EPS in Rs 0.81 0.39 1.48 3.99 8.78 5.45 6.10 8.30 12.82 15.04
Dividend Payout % 19% 51% 17% 4% 2% 4% 3% 2% 5%
Compounded Sales Growth
10 Years:-24%
5 Years:-12%
3 Years:-21%
TTM:-36%
Compounded Profit Growth
10 Years:24%
5 Years:25%
3 Years:30%
TTM:43%
Stock Price CAGR
10 Years:32%
5 Years:35%
3 Years:46%
1 Year:177%
Return on Equity
10 Years:%
5 Years:22%
3 Years:20%
Last Year:25%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions
Mar 2008 Mar 2009 Mar 2010 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Sep 2020
28 27 27 53 53 53 53 51 51 51
Reserves 314 304 311 474 750 858 1,032 1,157 1,367 1,858
Borrowings 423 475 408 -0 9 -0 -0 -0 -0 -0
181 209 251 91 64 81 73 57 53 78
Total Liabilities 946 1,015 997 619 875 992 1,159 1,266 1,471 1,987
367 405 393 169 146 171 179 209 225 233
CWIP 22 7 4 2 -0 0 -0 -0 3 -0
Investments 14 8 8 299 605 732 913 1,001 1,133 1,686
543 595 591 149 124 89 67 55 110 67
Total Assets 946 1,015 997 619 875 992 1,159 1,266 1,471 1,987

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
54 123 149 22 10 52 24 22 6
-225 -56 -24 5 -5 -47 -22 68 57
39 -70 -118 -25 -5 -5 -3 -89 -6
Net Cash Flow -133 -2 7 2 -0 -0 -1 1 57

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
ROCE % 7% 10% 4% 4% 4% 4% 7%
Debtor Days 85 71 63 122 76 54 74 40 44
Inventory Turnover 2.67 2.48 0.69 0.76 1.18 1.39 0.91

Shareholding Pattern

Numbers in percentages

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021
63.54 63.54 64.01 64.57 65.22 66.31 67.09 67.62 69.57 70.41 70.41 70.88
1.20 1.10 1.14 1.04 1.29 1.89 1.95 1.80 1.86 1.84 1.75 1.60
5.11 5.54 5.65 5.81 5.83 5.91 5.94 5.94 4.02 3.95 3.95 4.34
30.15 29.82 29.20 28.58 27.66 25.89 25.01 24.64 24.55 23.80 23.88 23.18

Documents

Recent announcements


View all

Annual reports

Credit ratings